%A Xie Wenyao, Jiang Da, Yang Zhiyong, Dong Qian %T Advances in research of rhendostatin in the treatment of cancer %0 Journal Article %D 2016 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2016.05.010 %P 360-363 %V 43 %N 5 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9954.shtml} %8 2016-05-08 %X Recombinant human endostatin (Endostar) is a broad spectrum molecular targeted drug on antiangiogenesis that the main evidencebased data is combined chemotherapy treatment of advanced nonsmall cell lung cancer (NSCLC). In recent years, the researches of recombinant human endostatin used in the treatment of various malignant tumors are on the increase and achieve good effect. In addition, the researches about combined treatment methods, routes of administration, methods of medication are carried out gradually, which will be conducive to the reasonable application in clinical.